Cargando…
Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect
FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448169/ https://www.ncbi.nlm.nih.gov/pubmed/32767480 http://dx.doi.org/10.1002/acn3.51095 |
_version_ | 1783574447638183936 |
---|---|
author | Correa‐Vela, Marta Lupo, Vincenzo Montpeyó, Marta Sancho, Paula Marcé‐Grau, Anna Hernández‐Vara, Jorge Darling, Alejandra Jenkins, Alison Fernández‐Rodríguez, Sandra Tello, Cristina Ramírez‐Jiménez, Laura Pérez, Belén Sánchez‐Montáñez, Ángel Macaya, Alfons Sobrido, María J. Martinez‐Vicente, Marta Pérez‐Dueñas, Belén Espinós, Carmen |
author_facet | Correa‐Vela, Marta Lupo, Vincenzo Montpeyó, Marta Sancho, Paula Marcé‐Grau, Anna Hernández‐Vara, Jorge Darling, Alejandra Jenkins, Alison Fernández‐Rodríguez, Sandra Tello, Cristina Ramírez‐Jiménez, Laura Pérez, Belén Sánchez‐Montáñez, Ángel Macaya, Alfons Sobrido, María J. Martinez‐Vicente, Marta Pérez‐Dueñas, Belén Espinós, Carmen |
author_sort | Correa‐Vela, Marta |
collection | PubMed |
description | FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368C>G (p.S123*) FBXO7 mutation was identified in a child with spastic paraplegia, epilepsy, cerebellar degeneration, levodopa nonresponsive parkinsonism, and brain iron deposition. Patient’s fibroblasts assays demonstrated an absence of FBXO7 RNA expression leading to impaired proteasome degradation and accumulation of poly‐ubiquitinated proteins. Conclusion: This novel FBXO7 phenotype associated with impaired proteasome activity overlaps with neurodegeneration with brain iron accumulation disorders. |
format | Online Article Text |
id | pubmed-7448169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74481692020-08-31 Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect Correa‐Vela, Marta Lupo, Vincenzo Montpeyó, Marta Sancho, Paula Marcé‐Grau, Anna Hernández‐Vara, Jorge Darling, Alejandra Jenkins, Alison Fernández‐Rodríguez, Sandra Tello, Cristina Ramírez‐Jiménez, Laura Pérez, Belén Sánchez‐Montáñez, Ángel Macaya, Alfons Sobrido, María J. Martinez‐Vicente, Marta Pérez‐Dueñas, Belén Espinós, Carmen Ann Clin Transl Neurol Brief Communication FBXO7 is implicated in the ubiquitin–proteasome system and parkin‐mediated mitophagy. FBXO7defects cause a levodopa‐responsive parkinsonian‐pyramidal syndrome(PPS). Methods: We investigated the disease molecular bases in a child with PPS and brain iron accumulation. Results: A novel homozygous c.368C>G (p.S123*) FBXO7 mutation was identified in a child with spastic paraplegia, epilepsy, cerebellar degeneration, levodopa nonresponsive parkinsonism, and brain iron deposition. Patient’s fibroblasts assays demonstrated an absence of FBXO7 RNA expression leading to impaired proteasome degradation and accumulation of poly‐ubiquitinated proteins. Conclusion: This novel FBXO7 phenotype associated with impaired proteasome activity overlaps with neurodegeneration with brain iron accumulation disorders. John Wiley and Sons Inc. 2020-08-06 /pmc/articles/PMC7448169/ /pubmed/32767480 http://dx.doi.org/10.1002/acn3.51095 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Correa‐Vela, Marta Lupo, Vincenzo Montpeyó, Marta Sancho, Paula Marcé‐Grau, Anna Hernández‐Vara, Jorge Darling, Alejandra Jenkins, Alison Fernández‐Rodríguez, Sandra Tello, Cristina Ramírez‐Jiménez, Laura Pérez, Belén Sánchez‐Montáñez, Ángel Macaya, Alfons Sobrido, María J. Martinez‐Vicente, Marta Pérez‐Dueñas, Belén Espinós, Carmen Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title | Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title_full | Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title_fullStr | Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title_full_unstemmed | Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title_short | Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect |
title_sort | impaired proteasome activity and neurodegeneration with brain iron accumulation in fbxo7 defect |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448169/ https://www.ncbi.nlm.nih.gov/pubmed/32767480 http://dx.doi.org/10.1002/acn3.51095 |
work_keys_str_mv | AT correavelamarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT lupovincenzo impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT montpeyomarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT sanchopaula impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT marcegrauanna impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT hernandezvarajorge impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT darlingalejandra impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT jenkinsalison impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT fernandezrodriguezsandra impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT tellocristina impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT ramirezjimenezlaura impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT perezbelen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT sanchezmontanezangel impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT macayaalfons impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT sobridomariaj impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT martinezvicentemarta impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT perezduenasbelen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect AT espinoscarmen impairedproteasomeactivityandneurodegenerationwithbrainironaccumulationinfbxo7defect |